Is it time to move away from ‘changing the treatment paradigm’ strategies?
Authored by Maxine Smith, Managing Director, and Strategic Consultant, Alexandra Fulford, Uptake Strategies for the PME Pharma Strategists’ Blog
In this article, Maxine and Alexandra discuss the treatment paradigm. Describing this level of change as a ‘treatment’ paradigm change does a disservice to the scale of change required and raises false expectations of what is achievable and by when.
They suggest continuing with a working example of bringing in more effective medicines earlier in disease management, then using strategy to build on the foundation created.
Most healthcare systems are trying to create a health paradigm shift, to preserve health and well-being and be pre-emptive, to slow and limit chronic conditions to afford the pressures of an ageing population.
